# Dixon Investments Inc – FDA Inspection, Dec 13, 2011

Source: https://www.keypedia.com/records/fda_inspections/dixon-investments-inc/9d05781a-caf8-419b-8614-1059df6ebac8
Source feed: FDA_Inspections

> FDA inspection 758691 of Dixon Investments Inc, December 13, 2011. Classification: Voluntary Action Indicated (VAI). 5 citations under 21 CFR part 211. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 758691
- Company Name: Dixon Investments Inc
- Inspection Date: 2011-12-13
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 5

## Related Documents

- [FDA Inspection 1263416 - 2025-03-11](https://www.keypedia.com/records/fda_inspections/dixon-investments-inc/91961a19-5a06-4d00-8690-898dde318914)
- [FDA Inspection 1083739 - 2019-03-22](https://www.keypedia.com/records/fda_inspections/dixon-investments-inc/bfeaee93-1a4b-4ff0-af85-cc713247e533)
- FDA Inspection 956550 - 2015-12-16
- FDA Inspection 858354 - 2013-12-06
- [FDA Inspection 646629 - 2010-01-25](https://www.keypedia.com/records/fda_inspections/dixon-investments-inc/fedfc68f-e4c9-4dc3-b464-bd6017ec6349)

Company: https://www.keypedia.com/companies/dixon-investments-inc/ce191609-e6f1-4391-8f04-21996703095d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
